Two Sigma Securities’s West Pharmaceutical WST Stock Holding History

Two Sigma Securities’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,532	Closed	-$635K	–	2450
2026 Q1	$635K	Buy	+2,532	New	+$630K	0.07%	378
2025 Q3	–	Sell	-5,837	Closed	-$1.28M	–	2072
2025 Q2	$1.28M	Buy	+5,837	New	+$1.25M	0.16%	159
2024 Q4	–	Sell	-1,466	Closed	-$440K	–	3348
2024 Q3	$440K	Buy	1,466 +97	+7%	+$29.7K	0.01%	1429
2024 Q2	$451K	Buy	1,369 +361	+36%	+$128K	0.01%	1637
2024 Q1	$399K	Sell	1,008 -257	-20%	-$95.1K	﹤0.01%	1738
2023 Q4	$445K	Buy	+1,265	New	+$448K	﹤0.01%	1641
2023 Q2	–	Sell	-1,309	Closed	-$454K	–	3422
2023 Q1	$454K	Buy	+1,309	New	+$382K	0.01%	1331
2022 Q4	–	Sell	-2,876	Closed	-$708K	–	3338
2022 Q3	$708K	Buy	+2,876	New	+$876K	0.02%	836
2022 Q2	–	Sell	-653	Closed	-$268K	–	2905
2022 Q1	$268K	Buy	+653	New	+$256K	0.01%	1489
2015 Q4	–	Sell	-3,981	Closed	-$215K	–	383
2015 Q3	$215K	Buy	+3,981	New	+$232K	0.34%	121

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Two Sigma Securities's WST Position: Q2 2026 in Review

Two Sigma Securities sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 2,532 shares — an estimated $635K sold.

Two Sigma Securities first reported a position in WST in Q3 2015 and held it in 10 quarters. The position peaked at $1.28M in Q2 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Two Sigma Securities reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 2,532 West Pharmaceutical shares in Q2 2026, an estimated $635K.
Two Sigma Securities first reported a position in West Pharmaceutical in Q3 2015 and held it in 10 quarters.
Two Sigma Securities's West Pharmaceutical position peaked at $1.28M in Q2 2025.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.